StockTipsArenaBeta

BUY Glenmark Pharmaceuticals — Prakash Gaba

BUYGlenmark Pharmaceuticals
Glenmark Pharmaceuticals share price target & all analyst calls

byPrakash GabaHorizon: NA (inferred Swing (≤2wk))27 Mar 2026via CNBC Awaaz.

Entry₹2,163Stated
Target₹2,230
Total upside +3.10% (call closed)
Stop loss₹2,150-0.60% risk
Exit₹2,15027 Mar 2026, 9:20 am
Stop-loss hit-0.60%
Follow Prakash Gaba for new calls(32% target hit, 342 closed calls)Get alertsWatch GLENMARK for new buy/sell callsGet alertsSee 2 active Swing calls on GLENMARKSee 282 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 15 Nov, 3:41 am IST
1 supporting0 opposing
Supports the BUY call (1)

Glenmark Pharmaceuticals Launches GLIPIQ® (Semaglutide) in India with Weekly Treatment Starting at ₹325

NewsGoogle News·23 Mar · 4d ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Glenmark Pharmaceuticals

All analyst calls on Glenmark Pharmaceuticals

More from Prakash Gaba

Every call and its outcome